DANIELLE EPSTEIN, NP
Medical-Surgical Registered Nurse in NEW HYDE PARK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
DANIELLE EPSTEIN, NP reported a CMS MIPS final score of 91.2532/100 — above the 83.1 national average — and filed 2,747 Medicare Part D claims in 2023.
- 91.2532/100
- MIPS score · +8 vs avg
- 3K
- Part D claims, 2023
- 51%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
DANIELLE EPSTEIN, NP's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
91 Top 37% higher than 63% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about DANIELLE EPSTEIN, NP?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New York
How Medical-Surgical Registered Nurse compares to other specialties among New York providers
Medical-Surgical Registered Nurse share within New York
Medical-Surgical Registered Nurse is one of the more visible NUCC categories in New York
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
DANIELLE EPSTEIN, NP's 2023 MIPS final score plotted against the Medical-Surgical Registered Nurse national average
- MIPS Final Score
- 91.2532/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Medical-Surgical Registered Nurse) — 91.2532/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Medical-Surgical Registered Nurse US NPIs
91.2532/100 MIPS final score — 8.2 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Medical-Surgical Registered Nurse. Quality dim: 74.9203.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
DANIELLE EPSTEIN, NP appears in the CMS NPPES registry as a Medical-Surgical Registered Nurse provider holding NP credentials at 3003 NEW HYDE PARK RD STE 401, NEW HYDE PARK, NY, 11042, with a listed phone of (516) 224-2400. NPI 1265004915 was issued on 07/13/2021. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what EPSTEIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,747 prescription claims written by this provider, covering 685 Medicare beneficiaries and totaling roughly $1.8 million in drug spend, split 49% brand-name and 51% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.2532/100 for the 2023 performance year (Quality 74.9203), compared with the national average of 83.1.
Medical-Surgical Registered Nurse is a narrow specialty nationwide, with 3,523 enrolled providers across 54 states and an average of 798 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1265004915 |
|---|---|
| Specialty | Medical-Surgical Registered Nurse |
| Credentials | NP |
| Gender | Female |
| NPI Issued | 07/13/2021 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm DANIELLE EPSTEIN, NP's current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
License & disciplinary context — New York NYSBPMC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to DANIELLE EPSTEIN, NP. To verify DANIELLE EPSTEIN, NP's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
49% brand-name claims vs 51% generic, on 2,747 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 7,036
- Total Day Supply
- 210,031
- Brand vs Generic
- 49% brand / 51% generic
- Brand Drug Cost
- $1.7M
- Generic Drug Cost
- $41K
Patient Demographics
- Average Patient Age
- 72.0 years
- Avg HCC Risk Score
- 1.47
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 73, 65-74: 359, 75-84: 205, 85+: 48
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What DANIELLE EPSTEIN, NP prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
310 claims
- Metformin Hcl
Metformin Hcl
206 claims
- Ozempic
Ozempic
158 claims
- Glimepiride
Glimepiride
156 claims
- Jardiance
Jardiance
152 claims
- Metformin Hcl Er 103
Metformin Hcl Er
103 claims
- Synthroid 89
Synthroid
89 claims
- Novolog Flexpen 87
Novolog Flexpen
87 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 310 |
| Metformin Hcl | 206 |
| Ozempic Semaglutide | 158 |
| Glimepiride | 156 |
| Jardiance Empagliflozin | 152 |
| Metformin Hcl Er Metformin Hcl | 103 |
| Synthroid Levothyroxine Sodium | 89 |
| Novolog Flexpen Insulin Aspart | 87 |
| Farxiga Dapagliflozin Propanediol | 69 |
| Mounjaro Tirzepatide | 49 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical-Surgical Registered Nurse Overview
How DANIELLE EPSTEIN, NP fits within the Medical-Surgical Registered Nurse landscape nationally.
DANIELLE EPSTEIN, NP's 2,747 claims are above the specialty average of 798.
Nearby Medical-Surgical Registered Nurse Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as EPSTEIN.
Compare Medical-Surgical Registered Nurse nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New York
Frequently Asked Questions
What is DANIELLE EPSTEIN, NP's specialty? ▼
How much does DANIELLE EPSTEIN, NP prescribe under Medicare Part D? ▼
What is DANIELLE EPSTEIN, NP's Medicare quality score? ▼
Where is DANIELLE EPSTEIN, NP located? ▼
What is DANIELLE EPSTEIN, NP's NPI number? ▼
Does DANIELLE EPSTEIN, NP prescribe more brand-name or generic drugs? ▼
How many Medical-Surgical Registered Nurse providers are there in the US? ▼
What drugs does DANIELLE EPSTEIN, NP prescribe most often? ▼
Does DANIELLE EPSTEIN, NP accept Medicare? ▼
How can I verify DANIELLE EPSTEIN, NP's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology